Eloxx Pharmaceuticals Inc expected to post a loss of $2.97 a share - Earnings Preview

Eloxx Pharmaceuticals

27/03/2023 12:25

* Eloxx Pharmaceuticals Inc  ELOX.OQ   ELOX.O  is expected
to show
no change in quarterly revenue when it reports  results on March
29 (estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Eloxx
Pharmaceuticals Inc
is for a loss of $2.97 per share. 
    * The one available analyst rating on the shares is "strong
buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Eloxx
Pharmaceuticals Inc is $50​, above​ its last closing price
of $2.83. ​​​

This summary was machine generated March 27 at 11:25 GMT.  All
figures in US dollars  unless otherwise stated